Table 2.
Laboratory values observed. Question: Which laboratory findings potentially linked to liver disease do you usually examine in routine lab work for general screening check-ups? (N = 2.701, GPs)
| Rotated component matrix | ||||
|---|---|---|---|---|
| Overall agreement | Comp. 1 (Expl. variation: 26,1%) | Comp. 2 (Expl. variation: 18,2%) | Comp. 3 (Expl. variation: 10,6%) | |
| Alanine aminotransferase (ALAT, ALT, GPT) | 63% | −.055 | .774 | −.119 |
| γ-glutamyltransferase (GGT) | 95% | −.040 | −.018 | .884 |
| Aspartate aminotransferase (ASAT, AST, GOT) | 65% | .141 | .576 | .386 |
| AP (alkaline phosphatase) | 62% | .542 | .252 | .305 |
| Ferritin | 26% | .734 | .035 | −.102 |
| Bilirubin | 46% | .686 | .219 | .213 |
| PT according to Quick (INR) | 27% | .663 | .207 | −.165 |
| Cholinesterase | 19% | .675 | .139 | −.023 |
| Albumin | 23% | .740 | −.027 | .092 |
| Platelet count | 57% | .256 | .715 | −.112 |
| MCV | 55% | .192 | .614 | .165 |
Extraction method: Principal component analysis
Rotation method: Varimax, Kaiser normalisation
Rotation in 4 iterations for convergence
Total explained variation: 54.9%
Sampling adequacy, Kaiser-Meyer-Olkin: .787
Significance, Bartlett: p < 0.001